http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020215069-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c73ca98ecc657a291b82dfd17729c39e
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2009-00891
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2009-00868
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-00802
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-007
filingDate 2020-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f15f3dfa882152e2a351cb79e0be8acc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_90ddd4099301b05501bfbc63e8283ecc
publicationDate 2020-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2020215069-A1
titleOfInvention Methods of transverse placement in elt
abstract Glaucoma patients suffer from increased intraocular pressure due to blocked fluid flow from the anterior chamber of the eye. Methods of the invention include inserting a probe into an eye of a subject having glaucoma, adjusting placement of the probe to a position transverse to Schlemm's canal in the eye, and applying a plurality of shots from an excimer laser source while the probe is in the transverse position, thereby treating glaucoma by creating a plurality of perforations in Schlemm's canal and/or the trabecular meshwork. By providing a laser probe at a position transverse to Schlemm's canal, energy from the laser is delivered to a greater amount of surface area than if the laser was arranged in a parallel or perpendicular position to Schlemm's canal, resulting in optimal formation of perforations. The perforations allow for drainage of fluid and increased outflow of aqueous humor in the eye.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11185444-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11583443-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11583444-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11318046-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11318047-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11529260-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11191670-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11234866-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11071647-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11590024-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11723805-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11759357-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11464677-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11058582-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11318045-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11633234-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11103382-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11076933-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11666482-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11672475-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11389239-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11185443-B2
priorityDate 2019-04-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2017202708-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013085484-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226421126
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413517
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413516
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5411
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406004
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3676
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5282419
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2474

Total number of triples: 47.